Integra acquires ACell for their ortho tissue business for $400M

Integra LifeSciences to acquire ACell (MassDevice)
Integra LifeSciences (NSDQ:IART) today said it entered into a definitive agreement to acquire ACell.

Through the deal, Integra LifeSciences will pay $300 million in cash upfront at closing, subject to customary purchase price adjustments with cash payments of up to an additional $100 million upon certain revenue growth milestones.
Columbia, Md.-based ACell currently develops The MatriStem UBM porcine urinary bladder matrix platform technology. The acquisition will help expand Integra Lifesciences orthopedics and tissue technologies bus...